|Number of pages||2|
|Journal||Journal of Allergy and Clinical Immunology: In Practice|
|Publication status||Published - 1 Mar 2015|
Bibliographical noteFunding Information:
This report is independent research commissioned and funded by the Department of Health Policy Research Programme (National Vaccine Evaluation Consortium, 039/0031). The views expressed in this publication are those of the author(s) and not necessarily those of the Department of Health.
P. J. Turner is in receipt of a Clinician Scientist award funded by the UK Medical Research Council (Grant reference MR/K010468/1) and has received research support from the Department of Health through the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre awards to Imperial College London Healthcare NHS Trust.
Conflicts of interest: P. J. Turner has received research support from the Department of Health , NHS National Institute for Health Research , and UK Medical Research Council . M. Erlewyn-Lajeunesse has received support for attendance at scientific meetings from Allergy Therapeutics , ALK Albelo , MEDA Pharmaceuticals , and Thermo Fisher .